The alliance, originally announced in November 2023, combines Almirall’s dermatological capabilities with Absci’s Integrated ...

The UK government has published its 10-Year Health Plan for England, which will see millions of patients being treated and ...

Ianalumab has a dual mechanism of action, B-cell depletion and BAFF-R inhibition, and is being investigated across various B ...